Michael D. West
2014 - BioTime
In 2014, Michael D. West earned a total compensation of $1.5M as Chief Executive Officer at BioTime, a 5% decrease compared to previous year.
Compensation breakdown
| Bonus | $204,000 |
|---|---|
| Option Awards | $624,115 |
| Salary | $680,315 |
| Other | $38,000 |
| Total | $1,546,430 |
West received $680.3K in salary, accounting for 44% of the total pay in 2014.
West also received $204K in bonus, $624.1K in option awards and $38K in other compensation.
Rankings
In 2014, Michael D. West's compensation ranked 5,607th out of 13,032 executives tracked by ExecPay. In other words, West earned more than 57.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,607 out of 13,032 | 57th |
Division Manufacturing | 2,007 out of 4,965 | 60th |
Major group Chemicals And Allied Products | 681 out of 1,690 | 60th |
Industry group Drugs | 529 out of 1,369 | 61st |
Industry Biological Products, Except Diagnostic Substances | 95 out of 241 | 61st |
Source: SEC filing on June 11, 2015.
West's colleagues
We found five more compensation records of executives who worked with Michael D. West at BioTime in 2014.
News
AgeX Therapeutics CEO Michael West's 2020 pay falls 46% to $561K
November 24, 2021
AgeX Therapeutics CEO Michael West's 2019 pay falls 24% to $1M
November 24, 2020
AgeX Therapeutics CEO Michael West's 2018 pay rises 2% to $1.7M
November 29, 2019
BioTime CEO Brian Culley's 2018 pay jumps 75% to $2.8M
June 14, 2019